Evidence map›Paper›PMID 39479991›Full record

ArticleEuropean journal of translational myology2024

Endocrine disorders in Kearns-Sayre syndrome with different severity of symptoms: two case reports and a literature review.

Ilya I Amergoolov, Yulia I Khruleva, Maria G Pavlova, Natalia V Likhodey, Abu M Sulaev, Elena V Surkova, Yulia P Sych, Marina F Kalashnikova, Anna S Arustamyan, Gratsinna A Martirosyan and 1 more

Abstract read
In one paragraph

Article in European journal of translational myology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ilya I AmergoolovDepartment of Endocrinology №1, First Moscow State Medical University (Sechenov University), Moscow. ilya_a94@mail.ru.
Yulia I KhrulevaDepartment of Endocrinology №1, First Moscow State Medical University (Sechenov University), Moscow. hruleva1994@mail.ru.
Maria G PavlovaDepartment of Endocrinology №1, First Moscow State Medical University (Sechenov University), Moscow. mgp.doc@yandex.ru.
Natalia V LikhodeyDepartment of Endocrinology №1, First Moscow State Medical University (Sechenov University), Moscow. nettle_l@yahoo.com.
Abu M SulaevRepublican Endocrinological Dispensary, Grozny, Chechen Republic. dr.sulaev@mail.ru.
Elena V SurkovaDepartment of Endocrinology №1, First Moscow State Medical University (Sechenov University), Moscow. elenasurkova@mail.ru.
Yulia P SychDepartment of Endocrinology №1, First Moscow State Medical University (Sechenov University), Moscow. juliasytch@mail.ru.
Marina F KalashnikovaDepartment of Endocrinology №1, First Moscow State Medical University (Sechenov University), Moscow. marina_kalash@mail.ru.
Anna S ArustamyanDepartment of Endocrinology №1, First Moscow State Medical University (Sechenov University), Moscow. arustamyan.annet@mail.ru.
Gratsinna A MartirosyanPirogov Russian National Research Medical University, Moscow. suzi-doc@mail.ru.
Simione T Lew-GorBox Hill Hospital, Eastern Health, Melbourne. s.lewgor@btinternet.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kearns-Sayre Syndrome (KSS) is a variant of mitochondrial disorder caused by a Mitochondrial Deoxyribonucleic Acid (mtDNA) deletion. Clinical manifestations of KSS can include different organ and system involvement. Different organ malfunctions, more often cardiac dysfunction, can lead to death. No effective treatment of this condition exists to date. Here, we report two patients with KSS. Female patient with a large-scale deletion of 7,020 base pairs (bp) suffered from hypogonadism, diabetes mellitus with fluctuating glucose levels, and had poor general health. A male patient with a common 4,977 bp deletion did not have diabetes mellitus but had impaired glucose tolerance. He also had a higher level of general health than our female patient. Both patients had reduced Bone Mineral Density (BMD). In female patients, calcium and vitamin D supplementation combined with metabolic therapy and nutritional drink supplements helped increase BMD (up to 32% in L1-L4). Comparing these two patients suggests that the larger the mtDNA deletion is, the more severe the course of the disease is. Not only does the size of the mtDNA deletion probably determine the severity of the disease, but also such factors as mtDNA heteroplasmy level, presence of mtDNA duplications, and pleioplasmy. Moreover, continuous nonconsecutive metabolic therapy and nutritional supplements are helpful in the prevention of deterioration of symptoms and general health.

Identifiers

PMID39479991
PMCPMC11726174

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.